Protein RS15A as a marker for colorectal cancer
OwnerMichael Tacke, Marie-Luise Hagmann +6inventors
InventorsMichael Tacke, Marie-Luise Hagmann, Johann Karl, Michael Pfeffer, Herbert Andres, Michael Thierolf, Norbert Wild, Werner Zolg
Life of this patent
Estimating the term…
Abstract
The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein RS15A (ribosomal protein S15a) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring RS15A in said sample. Measurement of RS15A can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Claims10
A method for assessing colorectal cancer in a patient comprising:
- measuring in a sample from said patient a concentration of RS15A (ribosomal protein S15a), and using the concentration measured in the assessment of colorectal cancer.
A marker panel comprising a specific binding agent for RS15A and a specific binding agent for a known marker of colorectal cancer.
A kit for assessing colorectal cancer in a patient, said kit comprising reagents for measuring RS15A.
Dependencies are inferred from the claim text.